Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$12.18 USD

12.18
3,593,469

+0.18 (1.50%)

Updated Aug 7, 2025 04:00 PM ET

After-Market: $12.18 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 6% (231 out of 246)

Industry: Chemical - Diversified

Zacks News

Zacks Equity Research

Chemours (CC) Earnings Expected to Grow: Should You Buy?

Chemours (CC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Sejuti Banerjea headshot

The Chemicals Market Is Evolving and Growing: 8 Picks

The chemical-diversified industry is poised to grow strongly over the next few years, so this is a great time to get some exposure.

Zacks Equity Research

Is Chemours (CC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Chemours (CC) Breaks Ground on New Mining Facility in Florida

Chemours (CC) expands mining projects in Florida, ensuring environmentally sustainable methods and job creation.

Zacks Equity Research

Why Chemours (CC) Stock Might be a Great Pick

Chemours (CC) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.

Zacks Equity Research

Is Chemours (CC) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

This 1 Basic Materials Stock Could Beat Earnings: Why It Should Be on Your Radar

Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.

Zacks Equity Research

Zacks.com featured highlights include: Macy's, Adient, Imperial Oil, Ryder System and The Chemours Co

Zacks.com featured highlights include: Macy's, Adient, Imperial Oil, Ryder System and The Chemours Co

Rimmi Singhi headshot

5 Top-Ranked Stocks Displaying High Earnings Yield

Earnings yield is an important tool for investors with exposure to both stocks and bonds.

Zacks Equity Research

Why You Should Add Chemours (CC) Stock to Your Portfolio Now

Chemours (CC) benefits from increasing adoption of the Opteon platform and its efforts to reduce costs.

Zacks Equity Research

CC or PPG: Which Is the Better Value Stock Right Now?

CC vs. PPG: Which Stock Is the Better Value Option?

Zacks Equity Research

Are Investors Undervaluing Chemours (CC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Is Chemours (CC) Stock a Solid Choice Right Now?

Chemours (CC) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

Anindya Barman headshot

Strong Demand, Manufacturing Upswing Buoy Chemicals: 5 Top Picks

A strong revival in industrial demand and strengthening manufacturing activities are driving the upturn in the chemical industry. DOW, OLN, UNVR, WLK and CC are good options for investment right now.

Zacks Equity Research

Chemours (CC) Stock Hits 52-Week High: What's Driving It?

Chemours (CC) is gaining from higher demand for Opteon in mobile applications and cost-cutting measures.

Zacks Equity Research

Why Is Chemours (CC) Up 18.5% Since Last Earnings Report?

Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks Equity Research

Chemours' (CC) Opteon XL41 Selected by Johnson Controls

Chemours (CC) has been selected by Johnson Controls to provide Opteon XL41 for the latter's HVAC products to facilitate the phase out of high GWP options.

Zacks Equity Research

Is Chemours (CC) a Great Value Stock Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Chemours (CC) Hits 52-Week High, Can the Run Continue?

Chemours (CC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Zacks Equity Research

Here's Why Chemours (CC) is a Great Momentum Stock to Buy

Does Chemours (CC) have what it takes to be a top stock pick for momentum investors? Let's find out.

Rimmi Singhi headshot

Book Profits by Investing in These High Earnings Yield Picks

Invest in high earnings yield stocks like PBR, HIMX, TEN and CC for sturdy gains.

Zacks Equity Research

Should Value Investors Buy Chemours (CC) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

Chemours (CC) Earnings and Revenues Beat Estimates in Q1

Chemours' (CC) Q1 results benefit from higher sales in Titanium Technologies and Advanced Performance Materials units driven by demand recovery.

Zacks Equity Research

Chemours (CC) Surpasses Q1 Earnings and Revenue Estimates

Chemours (CC) delivered earnings and revenue surprises of 4.41% and 3.80%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

John Blank headshot

Will Central Banks Start to Care About Fundamentals?

Macro-data has been much stronger than expected.¿¿¿¿¿¿ Still, the only thing that matters is NOT whether stock traders (or pundits) take note of strong data. It is whether the Fed and other major central banks care.